CardioVascular BioTherapeutics (fka CVBT)

[walhall]

Question 15: “Rumors” are that “one of the largest financial institutions in the world” is about to invest in Venturis Therapeutics (formerly CVBT). Who are the candidates?

A) No one is going to invest in an insolvent, illiquid, bankrupt company that is controlled and run by an individual the U.S. government alleges is a crook—Calvin Wallen III.

B) The North Korean Sovereign Wealth Fund

C) Deutsche Bank – a bank very comfortable investing in companies owned by crooks

D) The private bank of Vladimir Putin, the world’s richest man

E) J. Kushner & Co-Conspirators International Bank

F) First Jersey Securities

(The correct answer is listed below)

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047

The correct answer is: (A). Literally no one—credible, crooked, or anywhere inbetween—is going to invest in Venturis Therapeutics. Why? Because according to Venturis CFO Robert Schleizer in 2018, the company received a going concern qualification from its auditors, which confirms it’s insolvent (and nothing has changed since then). And since Bankruptcy Judge Gary Spraker indicated Venturis/CVBT is unable to pay its debts as they become due, it’s illiquid. And with Calvin Wallen III being accused by the U.S. government of having stolen $14 million from his previous company, well, that’s the certain kiss of death. Anyone who thinks that any prospective investor conducing proper due diligence on Venturis Therapeutics would somehow miss finding any or all of these inconvenient facts, well, there’s probably a greater chance that a certain drunkard in Venturis Therapeutics's leadership has quit drinking as he publicly insists (except for the evidence of him passing out at public events and needing to be carried away because he couldn’t walk on his own). So why are we seeing these rumors? I believe that question is sufficiently answered in our quiz earlier in Question 10, which you can find linked below.

Maybe this is a good time to review what a high-placed Venturis Therapeutics insider who left the company had to say:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891

And here are the earlier questions in our series:

Question 1: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716885

Question 2: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155768166

Question 3: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155830431

Question 4: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155887684

Question 5: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156041065

Question 6: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156227658

Question 7: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156355920

Question 8: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156535390

Question 9: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156702737

Question 10: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156857356

Question 11: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156983504

Question 12: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157124141

Question 13: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157392141

Question 14: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157474813